Subscribe to Newsletter

Retina

Subspecialties Retina

From FAME to the Real World

When it comes to newly approved treatments, real-world evidence is always eagerly anticipated

Subspecialties Retina

Would You Let Sleeping Dogmas Lie?

| Tiarnan Keenan

A new association is identified between sleep apnea and AMD, which could put the OSA and POAG theory to bed

Subspecialties Health Economics and Policy

ROP in the Digital Era

| Michael F. Chiang

Indirect ophthalmoscopy is the gold standard for ROP diagnosis, but it comes with multiple challenges: logistical difficulties, legal liability, reproducibility problems, and a skills gap. Is telemedicine the answer?

Business & Profession Retina

CATT: Five Years On

| Mark Hillen

The five-year follow-up data are in. Half of all patients retain BCVA of 20/40 or better, irrespective of drug used

Subspecialties Basic & Translational Research

On the KUSp of Neuroprotective Medicine

Novel compounds prevent disease progression in mouse models of glaucoma

Subspecialties Basic & Translational Research

Enter the Inflammasome

In the quest to unearth alternative treatment strategies that don't rely on VEGF inhibition, researchers made some surprising discoveries...

Business & Profession Retina

Retinal Imaging: From von Helmholtz to the Future

A journey from pencil drawings of retinal pathology to fluorescence lifetime imaging ophthalmoscopy. By Frank Holz

Subspecialties Retina

Photoreceptor Death, Thanks to a Low-Fat Diet

| Mark Hillen

Retinal angiomatous proliferation (RAP) is driven by oxygen deprivation, right? The road to retinal VEGF expression might be driven, in part, by energy deficiency

Subspecialties Retina

10,000th SPECTRALIS hits the market

Heidelberg Engineering has reached an important corporate milestone with the 10,000th SPECTRALIS® diagnostic imaging platform, which has been delivered to a French retina specialist.

Subspecialties Basic & Translational Research

The Polymath Molecule

From cornea to retina, NGF’s regenerative and neuroprotective potential seems immense. What does the future hold for this versatile little neurotrophin?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: